The AIM-HI Accelerator Fund is a 501(c)(3) non-profit organization founded in 2019 by the National Foundation for Cancer Research. Based in Rockville, Maryland, the organization is dedicated to providing oncology and STEM startups with the resources necessary to advance innovative discoveries from the laboratory to clinical applications, ultimately benefiting patients battling cancer. Since its inception, AIM-HI has funded approximately 30 startup companies in the oncology and STEM sectors.

AIM-HI Accelerator Fund focuses on bridging the funding gap for early-stage oncology startups, particularly during the pre-clinical stage, which is often considered too risky for traditional venture capitalists. The organization provides seed funding and support to help these startups develop innovative cancer therapies and technologies, employing an impact investment model where returns from successful investments are reinvested into promising oncology discoveries and startups.

The AIM-HI Accelerator Fund offers mentorship, expert feedback, and visibility in the AIM-HI/NFCR ecosystem. Winning companies from the AIM-HI Venture Competitions receive catalytic early-stage investment consideration and strategic guidance to help them navigate the oncology landscape.

Q: What types of companies does AIM-HI support? A: AIM-HI supports oncology and patient-empowering health-tech startups. Q: How can I apply for funding? A: Applications can be submitted through the AIM-HI Venture Competition portal. Q: What is the next application deadline? A: The next deadline is not disclosed.